Clinical Trials › NCT06587828
Recruiting
A Biospecimen Collection Study to Identify the Targets of Disease-Reactive T Cells in Patients With Autoimmune Disease
Sponsored by TScan Therapeutics, Inc.
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 300
Target enrollment
9
U.S. states
Jan 2023
Start date
Jan 2027
Expected completion
Interventions / Treatments
Companion blood samples with procedure
Conditions studied
Multiple Sclerosis
Where this trial is running (12 sites)
Rhode Island3 sites
Cranston · Cranston · Cranston
California2 sites
Orange · Sherman Oaks
Illinois1 site
Skokie
Kentucky1 site
Lexington
Massachusetts1 site
Waltham
Pennsylvania1 site
Harrisburg
South Carolina1 site
Summerville
Texas1 site
Bellaire
Wisconsin1 site
Milwaukee
Participating MS centers on MS Buddy (2)
UK Neurology MS and Neuroimmunology
Lexington, KY
Lexington, KY
MS centers in Rhode Island
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Rhode Island centersCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
